FR2779145B1 - Nouvelles compositions pharmaceutiques - Google Patents

Nouvelles compositions pharmaceutiques

Info

Publication number: FR2779145B1
Authority: FR; France
Prior art keywords: pharmaceutical compositions; new pharmaceutical; new; compositions; pharmaceutical
Prior art date: 1998-05-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR9906629A

Other languages

English (en)

Other versions

FR2779145A1 (fr

Inventor

Steffen Lang

Kurt Liechti

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-26

Filing date

1999-05-26

Publication date

2004-07-30

1998-05-26 Priority claimed from GBGB9811200.6A external-priority patent/GB9811200D0/en

1998-08-19 Priority claimed from GBGB9818105.0A external-priority patent/GB9818105D0/en

1999-05-26 Application filed by Novartis AG filed Critical Novartis AG

1999-12-03 Publication of FR2779145A1 publication Critical patent/FR2779145A1/fr

2004-07-30 Application granted granted Critical

2004-07-30 Publication of FR2779145B1 publication Critical patent/FR2779145B1/fr

2019-05-26 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dispersion Chemistry (AREA)
Psychiatry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

FR9906629A 1998-05-26 1999-05-26 Nouvelles compositions pharmaceutiques Expired - Fee Related FR2779145B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9811200.6A GB9811200D0 (en)	1998-05-26	1998-05-26	Organic compounds
GBGB9818105.0A GB9818105D0 (en)	1998-08-19	1998-08-19	Organic compounds

Publications (2)

Publication Number	Publication Date
FR2779145A1 FR2779145A1 (fr)	1999-12-03
FR2779145B1 true FR2779145B1 (fr)	2004-07-30

Family

ID=26313736

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR9906629A Expired - Fee Related FR2779145B1 (fr)	1998-05-26	1999-05-26	Nouvelles compositions pharmaceutiques

Country Status (30)

Country	Link
US (2)	US20020156099A1 (fr)
EP (1)	EP1082119B1 (fr)
JP (1)	JP4083985B2 (fr)
KR (1)	KR20010043669A (fr)
CN (1)	CN1270714C (fr)
AR (1)	AR018376A1 (fr)
AT (1)	ATE257380T1 (fr)
AU (1)	AU755134B2 (fr)
BE (1)	BE1012143A5 (fr)
BR (1)	BR9910696A (fr)
CA (1)	CA2333154C (fr)
DE (2)	DE19983247T1 (fr)
DK (1)	DK1082119T3 (fr)
ES (1)	ES2214859T3 (fr)
FR (1)	FR2779145B1 (fr)
GB (1)	GB2353473A (fr)
HU (1)	HUP0102202A3 (fr)
ID (1)	ID27096A (fr)
IL (1)	IL139501A0 (fr)
IT (1)	IT1313551B1 (fr)
NO (1)	NO20005920L (fr)
NZ (1)	NZ508325A (fr)
PE (1)	PE20000537A1 (fr)
PL (1)	PL344245A1 (fr)
PT (1)	PT1082119E (fr)
RU (1)	RU2240121C2 (fr)
SK (1)	SK17752000A3 (fr)
TR (1)	TR200003502T2 (fr)
TW (1)	TW537894B (fr)
WO (1)	WO1999061025A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR018376A1 (es)	1998-05-26	2001-11-14	Novartis Ag	Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento
AU2003225260A1 (en) *	2002-04-22	2003-11-03	University Of Florida	Microemulsions for selective molecular separation
GB0220953D0 (en)	2002-09-10	2002-10-23	Novartis Ag	Organic compounds
US7842791B2 (en)	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
FR2935001B1 (fr) *	2008-08-14	2011-12-30	Commissariat Energie Atomique	Emulsion fluorescente
FR2934954B1 (fr)	2008-08-14	2011-07-22	Commissariat Energie Atomique	Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr)	2008-08-14	2011-07-08	Commissariat Energie Atomique	Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934953B1 (fr)	2008-08-14	2011-01-21	Commissariat Energie Atomique	Nanoemulsions de nanocristaux
SG11201505076UA (en) *	2012-12-31	2015-07-30	Jrx Biotechnology Inc	Liquid topical pharmaceutical nano-emulsion formulations

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3305689A1 (de)	1983-02-18	1984-08-23	Mack Chem Pharm	Pharmazeutische zubereitung mit retardwirkung
US5342625A (en) *	1988-09-16	1994-08-30	Sandoz Ltd.	Pharmaceutical compositions comprising cyclosporins
MY110227A (en)	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
DE4220616C2 (de)	1992-06-24	1994-12-22	Byk Gulden Lomberg Chem Fab	Dexniguldipin zur intravenösen Verabreichung
EP1142568A1 (fr)	1992-09-25	2001-10-10	Novartis AG	Compositions pharmaceutiques à base de cyclosporines
GB2278780B (en) *	1993-05-27	1998-10-14	Sandoz Ltd	Macrolide formulations
CA2185803C (fr) *	1994-03-18	2006-07-11	Edward M. Rudnic	Systemes d'administration de medicaments emulsionnes
TW397825B (en) *	1994-10-14	2000-07-11	Novartis Ag	Aroyl-piperidine derivatives
GB2308545B (en)	1994-10-26	1999-06-02	Novartis Ag	Pharmaceutical microemulsion preconcentrates
IL129547A (en) *	1994-10-26	2001-01-11	Novartis Ag	Pharmaceutical compositions comprising a macrolide and an acid
FR2728165A1 (fr) *	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
US5886011A (en)	1995-03-27	1999-03-23	Hisamitsu Pharmaceutical Co., Inc.	Piperidine derivatives as substance P antagonists
NZ280689A (en)	1995-12-15	1997-08-22	Bernard Charles Sherma Sherman	Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
GB9601120D0 (en)	1996-01-19	1996-03-20	Sandoz Ltd	Organic compounds
WO1997045119A1 (fr)	1996-05-24	1997-12-04	Novartis Ag	Utilisation d'antagonistes de la substance p pour traiter la phobie sociale
AR018376A1 (es)	1998-05-26	2001-11-14	Novartis Ag	Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento

1999
- 1999-05-24 AR ARP990102454A patent/AR018376A1/es not_active Application Discontinuation
- 1999-05-24 TW TW088108449A patent/TW537894B/zh not_active IP Right Cessation
- 1999-05-25 BE BE9900364A patent/BE1012143A5/fr not_active IP Right Cessation
- 1999-05-25 PE PE1999000436A patent/PE20000537A1/es not_active Application Discontinuation
- 1999-05-26 GB GB0028506A patent/GB2353473A/en not_active Withdrawn
- 1999-05-26 RU RU2000133308/15A patent/RU2240121C2/ru not_active IP Right Cessation
- 1999-05-26 ID IDW20002316A patent/ID27096A/id unknown
- 1999-05-26 DE DE19983247T patent/DE19983247T1/de not_active Withdrawn
- 1999-05-26 WO PCT/EP1999/003623 patent/WO1999061025A1/fr not_active Ceased
- 1999-05-26 TR TR2000/03502T patent/TR200003502T2/xx unknown
- 1999-05-26 AT AT99927760T patent/ATE257380T1/de not_active IP Right Cessation
- 1999-05-26 EP EP99927760A patent/EP1082119B1/fr not_active Expired - Lifetime
- 1999-05-26 ES ES99927760T patent/ES2214859T3/es not_active Expired - Lifetime
- 1999-05-26 DK DK99927760T patent/DK1082119T3/da active
- 1999-05-26 CA CA002333154A patent/CA2333154C/fr not_active Expired - Fee Related
- 1999-05-26 IL IL13950199A patent/IL139501A0/xx unknown
- 1999-05-26 NZ NZ508325A patent/NZ508325A/xx unknown
- 1999-05-26 PL PL99344245A patent/PL344245A1/xx unknown
- 1999-05-26 PT PT99927760T patent/PT1082119E/pt unknown
- 1999-05-26 HU HU0102202A patent/HUP0102202A3/hu unknown
- 1999-05-26 BR BR9910696-5A patent/BR9910696A/pt not_active Application Discontinuation
- 1999-05-26 IT IT1999MI001164A patent/IT1313551B1/it active
- 1999-05-26 CN CNB998066036A patent/CN1270714C/zh not_active Expired - Fee Related
- 1999-05-26 FR FR9906629A patent/FR2779145B1/fr not_active Expired - Fee Related
- 1999-05-26 DE DE69914077T patent/DE69914077T2/de not_active Expired - Lifetime
- 1999-05-26 JP JP2000550485A patent/JP4083985B2/ja not_active Expired - Fee Related
- 1999-05-26 AU AU45008/99A patent/AU755134B2/en not_active Ceased
- 1999-05-26 SK SK1775-2000A patent/SK17752000A3/sk unknown
- 1999-05-26 KR KR1020007012871A patent/KR20010043669A/ko not_active Ceased
2000
- 2000-11-23 NO NO20005920A patent/NO20005920L/no not_active Application Discontinuation
2002
- 2002-04-10 US US10/119,549 patent/US20020156099A1/en not_active Abandoned
2003
- 2003-03-04 US US10/379,345 patent/US6949257B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
RU2240121C2 (ru)	2004-11-20
HK1035137A1 (en)	2001-11-16
JP4083985B2 (ja)	2008-04-30
DK1082119T3 (da)	2004-04-13
ES2214859T3 (es)	2004-09-16
NO20005920D0 (no)	2000-11-23
TW537894B (en)	2003-06-21
BE1012143A5 (fr)	2000-05-02
EP1082119A1 (fr)	2001-03-14
TR200003502T2 (tr)	2001-04-20
PT1082119E (pt)	2004-05-31
HUP0102202A2 (hu)	2001-11-28
GB0028506D0 (en)	2001-01-10
JP2002516280A (ja)	2002-06-04
CN1270714C (zh)	2006-08-23
IL139501A0 (en)	2001-11-25
ID27096A (id)	2001-03-01
SK17752000A3 (sk)	2001-05-10
BR9910696A (pt)	2001-01-30
ITMI991164A1 (it)	2000-11-26
AU755134B2 (en)	2002-12-05
US20030152626A1 (en)	2003-08-14
PL344245A1 (en)	2001-10-08
KR20010043669A (ko)	2001-05-25
DE69914077D1 (de)	2004-02-12
FR2779145A1 (fr)	1999-12-03
ATE257380T1 (de)	2004-01-15
WO1999061025A1 (fr)	1999-12-02
CA2333154C (fr)	2008-07-08
EP1082119B1 (fr)	2004-01-07
HUP0102202A3 (en)	2003-01-28
AU4500899A (en)	1999-12-13
DE69914077T2 (de)	2004-06-09
AR018376A1 (es)	2001-11-14
CN1303285A (zh)	2001-07-11
US20020156099A1 (en)	2002-10-24
PE20000537A1 (es)	2000-07-10
NZ508325A (en)	2003-06-30
CA2333154A1 (fr)	1999-12-02
GB2353473A (en)	2001-02-28
US6949257B2 (en)	2005-09-27
DE19983247T1 (de)	2001-05-31
NO20005920L (no)	2001-01-25
IT1313551B1 (it)	2002-09-09

Publication	Publication Date	Title
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
FI991485A0 (fi)	1999-06-30	Uusi farmaseuttinen koostumus
EA199900373A3 (ru)	2000-08-28	Фармацевтические композиции
ID27415A (id)	2001-04-05	Komposisi farmaseutik
NO20015175L (no)	2001-10-23	Farmasöytisk sammensetning
NO20005913L (no)	2001-01-22	Legemiddelsammensetning
PT1242087E (pt)	2004-06-30	Composicoes farmaceuticas
NO20012915L (no)	2001-08-13	Ny farmasöytisk formulering
FR2804025B1 (fr)	2002-08-23	Compositions pharmaceutiques stabilisees
ID29262A (id)	2001-08-16	Komposisi farmasi
ID27201A (id)	2001-03-08	Komposisi farmasi
ITMI982222A0 (it)	1998-10-16	Composizioni farmaceutiche orali contenenti buprenorfina
FR2802423B1 (fr)	2005-03-25	Compositions pharmaceutiques
IS5184A (is)	1999-09-17	Lyfjasamsetningar
FR2779145B1 (fr)	2004-07-30	Nouvelles compositions pharmaceutiques
ID30032A (id)	2001-11-01	Formulasi farmasi
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi)	2000-07-20	Farmaseuttinen koostumus
EE200100281A (et)	2002-08-15	Analgeetiline ravimkoostis
EE200000330A (et)	2001-08-15	Farmatseutilised kompositsioonid
MA26604A1 (fr)	2004-12-20	Compositions pharmaceutiques.
NO994436L (no)	1999-09-13	Farmasöytiske sammensetninger
FI981567A0 (fi)	1998-07-07	Farmaseuttiset koostumukset
SE9800330D0 (sv)	1998-02-05	Pharmaceutical compositions
SE9800052D0 (sv)	1998-01-13	Pharmaceutical compositions

Legal Events

Date	Code	Title	Description
2012-02-17	ST	Notification of lapse	Effective date: 20120131